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ABSTRACT
The Spinal Muscular Atrophy (SMA) gene SMN was
recently duplicated (SMN1 and SMN2) in higher pri-
mates. Furthermore, invasion of the locus by repet-
itive elements almost doubled its size with respect
to mouse Smn, in spite of an almost identical
protein-coding sequence. Herein, we found that SMN
ranks among the human genes with highest den-
sity of Alus, which are evolutionary conserved in
primates and often occur in inverted orientation. In-
verted repeat Alus (IRAlus) negatively regulate splic-
ing of long introns within SMN, while promoting
widespread alternative circular RNA (circRNA) bio-
genesis. Bioinformatics analyses revealed the pres-
ence of ultra-conserved Sam68 binding sites in SMN
IRAlus. Cross-link-immunoprecipitation (CLIP), mu-
tagenesis and silencing experiments showed that
Sam68 binds in proximity of intronic Alus in the
SMN pre-mRNA, thus favouring circRNA biogenesis
in vitro and in vivo. These findings highlight a novel
layer of regulation in SMN expression, uncover the
crucial impact exerted by IRAlus and reveal a role for
Sam68 in SMN circRNA biogenesis.
INTRODUCTION
The highly homologous SMN1 and SMN2 genes originate
from a chromosome 5 repeat at the human 5q13.3 locus and
encode for the essential Survival of Motor Neuron (SMN)
protein (1,2). Loss of function mutations in SMN1 are
linked to SpinalMuscular Atrophy (SMA), a genetically in-
herited disease caused by deficiency in SMNprotein expres-
sion and consequent degeneration of motor neurons in the
spinal cord, progressive muscle weakness and atrophy (3,4).
Although SMN2 potentially encodes the same protein, a
silent C-to-T substitution in exon 7 impairs its inclusion
in the mature mRNA and leads to transcripts encoding a
truncated and highly unstable isoform (SMN7) (5), which
does not suffice SMN function. After substantial transla-
tional research efforts in the last decades, therapies elicit-
ing clinical benefits for SMA patients have become avail-
able (6). The first FDA approved drug (Nusinersen) is an
antisense oligonucleotide (ASO) that restores SMN2 exon
7 splicing, thus ameliorating SMA phenotypes in mouse
models and patients (7–9). Next, a gene therapy approach
delivering the SMN1 gene through an adeno-associated vi-
ral vector was developed (10–12). Although both therapies
provide significant clinical improvement, neither one rep-
resents a complete cure for SMA yet and not all patients
respond equally to treatments. Thus, further understanding
of SMN expression regulation may pave the ground for ad-
ditional and more personalized therapeutic approaches.
The SMN1/2 (from hereafter referred to as SMN) lo-
cus undergoes extensive regulation, both at transcription
and splicing levels (13). Furthermore, recent evidence in-
dicates that the locus generates at least two antisense long
non-coding RNAs (lncRNAs) that impact on the sense
SMN transcripts. Indeed, both lncRNAs were shown to
repress transcription elongation within SMN through re-
cruitment of the polycomb (PRC2) complex (14,15). Impor-
tantly, their knockdown by specific ASOs induced SMN ex-
pression and improved the efficacy of Nusinersen in SMA
mice (14,15), suggesting that their regulation could be ex-
ploited to improve therapeutic strategies for SMA.
Another class of RNAs that can contribute to the regu-
lation of protein-coding RNAs are the circular RNAs (cir-
cRNAs) (16). They are produced by back-splicing reactions
in which a downstream 5′ splice site is covalently joint to
an upstream 3′ splice site, thus causing circularization of
the pre-mRNA (17,18). Since canonical splicing and back-
splicing utilize the same pre-mRNA and are both operated
by the spliceosome (19), they possibly compete with each
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other (16). Thousands of circRNAs have been discovered
in eukaryotic cells and their expression is often regulated
in a cell-type and stage-specific manner (20). Although the
majority of circRNAs still lacks functional annotations, re-
cent observations have revealed potentially important roles
in gene regulation (17,18). The main mechanism favouring
circRNA biogenesis is the presence of repetitive sequences
in inverted orientation, and in particular inverted Alu re-
peats (21). Furthermore, dimerization of RNAbinding pro-
teins (RBPs) that recognize intronic regions, such as the
STAR (Signal Transduction and Activation of RNA) pro-
tein QKI, was also shown to promote circRNA biogenesis
(22,23). Nevertheless, whether RBPs exploit Alus to medi-
ate this process is currently unknown.
Herein, we found that SMN rank among the top human
genes for Alu density, many of which are present in inverted
orientation. Strikingly,Alu pairing appears to interfere with
splicing of long introns while driving widespread alterna-
tive circularization of the SMN pre-mRNA. We also found
that the STAR protein Sam68 binds in proximity of Alus
in the SMN pre-mRNAs and favours circRNA biogenesis.
Our findings uncover a novel layer of regulation of theSMN
locus with possible implications also for SMA.
MATERIALS AND METHODS
Maintenance of type-I and type-II SMA mice
The SMA mouse models used were type-I FVB.Cg-Smn
1tm1HungTg(SMN2)2Hung/J (005058) and type-II FVB.
Cg-Tg(SMN2∗delta7)4299Ahmb Tg(SMN2)89Ahmb Sm
n1tm1Msd/J (005025) (The Jackson Laboratory). Breeding
and maintenance of mice were done in accordance with
the institutional guidelines of the IRCCS Fondazione Santa
Lucia and the approval of the Ethical Committee. This
study was performed in strict accordance with the recom-
mendations in the Guide for the Care and Use of Labora-
tory Animals of the Italian Ministry of Health. The pro-
tocol was approved by the Ministry of Health (permit no.
809 2015PR) and by the Committee on the Ethics of An-
imal Experiments of the IRCCS Fondazione Santa Lucia.
Every effort was made to minimize suffering of mice. Ge-
nomicDNA for genotyping was isolated from the tail by the
Biotool™MouseDirect PCRKit. Primers used for genotyp-
ing are listed in Supplementary Table S5.
Isolation and maintenance of murine hepatocytes harboring
the human SMN2 transgene
Liver from P0 and/or P1 newborns (Smn+/+;SMN2++)
were dissected, mechanically dissociated using a Potter
glass homogenizer and plated at high density on collagen
I (Transduction Laboratories) coated dishes in RPMI-1640
(Lonza), supplemented with 10% fetal bovine serum (FBS,
Gibco), 50 ng/ml epidermal growth factor, 30 ng/ml in-
sulin like growth factor II (PeproTech Inc), 10 mg/ml in-
sulin (Roche), 2 mmol/l L-glutamine, 100 mg/ml penicillin
and 100 mg/ml streptomycin (Gibco). After 12–24 h, cul-
tures were washed to remove all unattached cells, includ-
ing red blood cells, and the medium was replaced. The cul-
tures were maintained without transfer with medium re-
placement twice aweek.Within 4weeks themajority of cells
died and within 6 weeks colonies with distinct cell morphol-
ogy became visible and were isolated and propagated.
Cell culture and treatment
Human embryonic kidney 293T (HEK293T) and human
SMA type-I (GM03813) fibroblasts (Coriell Institute) were
cultured in Dulbecco’s modified Eagle’s medium Glu-
tamax (DMEM, Sigma-Aldrich) and Minimum Essen-
tial Medium + Glutamax (MEM, Gibco), respectively, at
37◦C under 5% CO2. Culture media were supplemented
with 10% (HEK293T) or 15% (GM03813) FBS (Gibco),
1% penicillin-streptomycin solution (Gibco) and 5% non-
essential amminoacids (Gibco).
For RNA stability, GM03813 cells were treated with in-
creasing amount of LDC067 (Selleckchem) for 24 h, as indi-
cated in the Supplementary Figure S2B. For ASO transfec-
tion, GM03813 cells were transduced by scraping delivery
according to the manufacturer’s instructions (Gene Tools)
with 10M of ASO-E8 (5′ ATCAAGAAGAGTTACCCA
TTCCACT 3′) or control ASO (ASO-C) (5′ TCATTTGC
TTCATACACAGG 3′). To label nascent SMN transcripts,
cell were incubated with DRB (75 M, Sigma Aldrich)
and, after DRB removal, nascent RNAs were labelled by
adding 2mM of BrU (Sigma Aldrich) to the fresh medium
for 60min. Labelled transcripts were immunoprecipitated
with 1g (for 5 g of total RNA) of anti-BrdU antibody
(Santa Cruz Biotechnology, Inc.) and isolated as previously
described (24).
Murine hepatocytes (2 × 105 cells/well) or human
HEK293T cells (4 × 105 cells/well) were transfected with
250 ng of circSMNminigenes and/or 500 ng of Flag-Sam68
plasmid (when indicated) in six-well plates by usingLipofec-
tamine 2000 (Invitrogen) and Opti-MEM medium (Gibco)
for 8 h. RNA and proteins were extracted 48 h after trans-
fection.
RNA interference
siRNA oligonucleotides used for silencing the expression of
DHX9 helicase and Sam68, hnRNP F/H and TIA-1 were
purchased from Sigma Aldrich. Non-targeting scrambled
siRNA was used as the negative control. All siRNA se-
quences utilized in this study are listed in Supplementary
Table S5. A total of 40 × 104 cells/well were transfected
with 100 pmol siRNA in six-well plates by using RNAiMax
(Invitrogen) andOpti-MEMmedium (Gibco). Transfection
was repeated on two consecutive days to increase silencing
efficiency. RNA and proteins were extracted 48 h after last
transfection.
RT-PCR and qPCR analyses
Total RNA was extracted by using Trizol reagent (Invit-
rogen). After digestion with RNase-free DNase (Roche),
1/2 g of total RNA was retro-transcribed with random
primers using M-MLV reverse transcriptase (Promega) ac-
cording tomanufacturer’s recommendations. 10%of cDNA
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was used as template for PCR (GoTaq, Promega) and re-
actions were analysed on 2% agarose gels. qPCR reactions
were performed using LightCycler 480 SYBRGreen IMas-
ter and the LightCycler 480 System (Roche), according to
manufacturer’s instructions. RNaseR (RNR07250, Epicen-
tre) treatment was performed on 5–10 g of total RNA
(3U/g of RNA) for 30′ at 37◦C. Digested RNA was retro-
transcribed as above. PCR products of interest were puri-
fied and sequenced (Eurofins Genomics). Primers used in
RT-PCR and qPCR experiments are listed in Supplemen-
tary Table S5.
Western blot analyses
Total proteins were extracted from cells or murine tis-
sues by using a lysis buffer (150 mM NaCl, 15 mM
MgCl2, 15 mM EGTA, 50 mM HEPES pH 7.4, 20 mM
-glycerophosphate, 10% glycerol, 1% Triton X-100) sup-
plemented with 1% protease inhibitor cocktail (Sigma
Aldrich), 0.5 mMNa3VO4, 1 mMDTT. Extracted proteins
were resolved on 10% SDS-PAGE gels (10–20 g/lane) and
transferred onto nitrocellulose membrane (Amersham).
Blots were incubated with the indicated primary anti-
body in 5% non-fat dry milk in PBS plus 0.1% Tween-
20 overnight at 4◦C. The primary antibodies used (1:1000)
were: rat anti-RNA polymerase II (phospho-CTD Ser-2)
(Millipore), mouse anti-RNA polymerase II (N-20), rabbit
anti-DHX9, mouse anti-GEMIN 2, mouse anti-ACTIN,
rabbit anti-Sam68, mouse anti-hnRNP F/H and goat anti-
TIA-1 (all from Santa Cruz Biotechnology, Inc.), mouse
anti-SMN (BD Biosciences). Detection was achieved us-
ing anti-rabbit, anti-mouse (GE Healthcare) and anti-rat
(Santa Cruz Biotechnology, Inc.) HRP-linked secondary
antibodies (1:10 000) and visualized by Immunocruz West-
ern Blotting Luminol Reagent (Santa Cruz Biotechnology,
Inc.).
UV-crosslinking immunoprecipitation
CLIP assays were performed as previously described (25).
In brief, cells were irradiated on ice (100 mJ/cm2). Cell sus-
pensionwas centrifuged at 4000 rpm for 5min and the pellet
was incubated for 10 min on ice in lysis buffer (50 mM Tris,
pH 8.0, 100 mM NaCl, 1% NP-40, 1 mM MgCl2, 0.1 mM
CaCl2, 0.5 mM Na3VO4, 1 mM DTT, protease inhibitor
cocktail (Sigma-Aldrich) and RNase inhibitor (Promega)).
Samples were briefly sonicated and incubated with DNase
(RNase-free; Ambion) for 3 min at 37◦C and then cen-
trifuged at 15 000g for 3min at 4◦C. For inputRNA, 1mg of
extract was treatedwith ProteinaseK for 30min at 55◦Cand
RNA was purified by standard procedure. For immunopre-
cipitation, 1 mg of extract was diluted to 1 ml with lysis
buffer and incubated with rabbit anti-Sam68, mouse anti-
hnRNP F/H and goat anti-TIA-1 (Santa Cruz Biotechnol-
ogy, Inc.) or IgGs (negative control) in the presence of pro-
tein G magnetic Dynabeads (Novox; Life Technologies).
1000 IU RNase I (Ambion) was added and reactions were
incubated for 2 h at 4◦C under rotation. After stringent
washes (25), an aliquot (10%) was kept as a control of im-
munoprecipitation, while the rest was treated with 50 g
Proteinase K and incubated for 1 h at 55◦C. RNA was then
isolated by standard procedures.
Plasmid constructs
circSMN minigene was amplified (PCR primers listed in
Supplementary Table S5) from Smn−/−;SMN2++ mouse
genome and cloned in pCI vector (Promega). Briefly,
tagged-exon 6megaprimer was amplified using primers #1–
2. Megaprimer and primer #3 were used to amplify 5′
end of circSMN minigene (E5-I6) that was digested with
KpnI and SalI restriction enzymes and cloned in pCI vector
(5′SMNcirc). 3′ end of circSMN (I6-3′dwr region) was am-
plified using primers #4–5. The 3′ end insert was digested
with SalI and NotI restriction enzymes and cloned in the
5′SMNcirc vector digested with the same enzymes. Deletion
of AluSq sequence in intron 5 was generated by amplify-
ing the inserts #3–6 and #7–2. Deletion of Sam68 binding
sites in intron 5 was generated by amplifying the inserts #3–
8 and #9–2. Double deletion was generated by amplifying
the inserts #3–6 and #9–2. All PCR amplicon generated for
the deletion mutations were digested with KpnI and SalI
restriction enzymes for subclining in pCI to generate pCI-
SMNcirc vectors.
Bioinformatics analysis
Alu sequences coordinates were retrieved from the UCSC
Genome Browser.Alu positions in SMN genes and links be-
tween pairs of Alus on opposite strands were plotted using
R and R package igraph (v1.2.1). For conservation analysis
of Alu elements in primates each subtype longest Alu se-
quence was aligned using T-Coffee tool (v11). The distance
between the aligned sequences was computed using dnadist
function from PHYLIP tool (v3.697). The distance matri-
ces obtained were used to plot the dendrograms in R. For
conservation analysis of SMN motifs within Alus, primate
SMN sequences and 1500 flanking base pairs (bp) were re-
trieved from theUCSCGenome Browser. Themotifs found
in the human sequence were searched in the other SMN ho-
mologues using Blast tool fromNCBI. For alignment of the
three selected Alumotifs with all other Alu elements on op-
posite strand we used the pairwise alignment function from
Biostring package in R and the identitymatrix (Supplemen-
tary Tables S1–S4). For this analysis we also included a 3000
bp intergenic sequence on each side of the SMN gene.
Quantification and statistical analysis
Quantitative data represent the mean ± standard deviation
(SD), as indicated in the figure legends. Unpaired t-test and
one-way analysis of variance (ANOVA) followed by Bonfer-
roni’s multiple comparison post-test were performed using
Prism 6 software (GraphPad Software). Power analysis was
performed using the G*Power software (version 3.1.9.2).
RESULTS
Invasion of inverted repeatAlu elements characterizes the hu-
man SMN locus
Alus belong to the primate-specific Short Interspersed Ele-
ments (SINE) family of retrotransposons, are ∼300 nt long
and account for up to 11% of the annotated human genome
(26). During evolution, insertion of Alu elements in introns
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has represented a major difference between human and
mouse SMN genes, which are instead highly conserved at
the exon level (Figure 1A). Notably, whole genome com-
parison of Alu density highlighted SMN among the top-
ranking human genes (Figure 1B). This feature was main-
tained also when only Alu-containing genes were consid-
ered (Figure 1B), or within protein-coding genes, which
displayed significantly higher density of Alu elements than
noncoding genes (P = 1.09e−53; Figure 1C). These obser-
vations indicate that the SMN locus has undergone a per-
vasive invasion of Alu elements upon evolution.
We identified multiple Alu subtypes in the SMN locus,
particularly the Jb, Y and Sx1, mapping to basically all
introns with the exception of smallest introns (2b, 3 and
7). On the other hand, the longest SMN introns, intron 1
and 6, show the highest number of Alus (Figure 1D). AluJb
elements were more frequent in intron 1, whereas AluY
elements are predominantly located in intron 6. Further-
more, several Alus were also located in intergenic regions
upstream and downstream of SMN (Figure 1D). Inspection
of Alu orientation revealed the presence of several inverted
repeats spanning the whole locus. On the basis of their se-
quence homology, we predicted that such inverted repeat
Alus (IRAlus) could potentially mediate intra-intronic (in
intron 1 and 6, Figure 1D, green lines), inter-intronic pairing
(Figure 1D, red lines), as well as pairing with intergenic re-
gions (Figure 1D, blue lines).Moreover, phylogenetic analy-
ses indicated that SMN IRAlus are evolutionary conserved
within primates (Supplementary Figure S1A). These obser-
vations suggest thatAlu invasion of the primate SMN genes
has added a new layer of regulation.
Inverted repeat Alus negatively impact on SMN transcript
processing
Mounting evidence shows that Alus can modulate the ex-
pression of their ‘host’ genes at multiple layers, including
transcription, splicing, export and translation (27). To in-
vestigate whether highAlu density impacts on transcription
dynamics, we evaluated the processivity of the RNA poly-
merase II (RNAPII) bymeasuring the ratio between a distal
and a proximal intron in human (SMN) and mouse (Smn)
pre-mRNAs (28). To rule out differences potentially due to
the cell or tissue context rather than to the gene under anal-
ysis, we analyzed transcripts expressed in mouse hepato-
cytes harboring the human SMN2 transgene (Supplemen-
tary Figure S1B, C). Quantitative real time PCR (qPCR)
analyses revealed a striking reduction inRNAPII processiv-
ity in the human SMN compared to murine Smn gene (Fig-
ure 2A). Furthermore, we observed similar low RNAPII
processivity in other human high-Alu genes (MARVELD2
and GOT2) with respect to low-Alu genes (CTDSP2 and
POLI), which were all selected for length (∼30 kb) and
number of exons (9–10) comparable with SMN (Figure
2B, C). By contrast, no substantial differencewith the corre-
spondingmouse orthologueswas observed for human genes
characterized by low Alu content (Figure 3D, Supplemen-
tary Figure S1D).
To test whether IRAlu pairing affected RNAPII proces-
sivity in SMN, we silenced DHX9, an RNA helicase that
unfolds IRAlu pairs (29). Silencing of DHX9 further re-
duced RNAPII processivity in the SMN locus in human
cells (Figure 2E, F), suggesting that increased Alu pair-
ing interferes with transcription elongation and/or pre-
mRNA processing. Accordingly, nascent RNA analysis
performed by immunoprecipitation of pulse-labelled tran-
scripts (Figure 2G) revealed that DHX9 knockdown re-
duced the splicing efficiency of Alu-rich introns (1 and 6),
whereas it exerted no impact on splicing of the Alu-less
intron 2b (Figure 2H). In line with lower RNA process-
ing efficiency, DHX9 depletion was accompanied by signif-
icant reduction in SMN protein levels (Figure 2I). This ef-
fect was specific as expression of GEMIN 2, a component
of the SMN complex, was unaffected in DHX9-depleted
cells (Figure 2I). These observations indicate that modula-
tion of IRAlu pairing could functionally impact on SMN
expression.
The SMN pre-mRNA undergoes widespread alternative cir-
cularization
Pairing of IRAlus, especially when located in proximity of
splice sites as in SMN (Figure 1D), may promote back-
splicing events (21). In support of this notion, inspection
of the deposited human circRNA sequences in Genome
Browser (www.genome.ucsc.edu) revealed the existence of
at least two SMN circRNAs, one containing exons 6 and
5 and the other containing exons 4, 2b and 3 (Supple-
mentary Figure S2A). RNA circularization is generally
favoured by pairing of long introns containing short and
highly conserved inverted repeat sequences (30). Based on
our bioinformatics analysis, pairing between intron 1 and
6, the longest introns in SMN, could be favoured by sev-
eral IRAlus (Figure 1D), thus potentially favouring back-
splicing between exon 6 and exon 2a (Figure 3A). To test
this hypothesis, RNA from human type-I SMA fibroblasts
(GM03813) and HEK293T cells was treated with RNAse
R to degrade linear RNAs while preserving circRNAs (21).
RT-PCR analyses using divergent primers in exon 2b and
exon 6 identified a product of ∼300 bp (Figure 3B). Direct
sequencing confirmed the back-splicing junction between
exon 6 and exon 2a, indicating that this product originates
from a circRNA (Figure 3B).
Due to their covalently closed conformation, circRNAs
are relatively more stable than linear RNAs and tend to ac-
cumulate in cells (17,20). Accordingly, we found that tran-
scriptional impairment with an inhibitor of RNAPII serine
2 phosphorylation (LDC067) did not affect the expression
level of this SMN circRNA, while reducing the abundance
of its linear counterpart (Supplementary Figure S2B). This
result confirms the occurrence of a back-splicing event be-
tween exon 6 and exon 2a of SMN.
Since multiple potential IRAlu pairs were observed in
the SMN locus, even within small size introns (Figure 2A),
we asked whether the SMN pre-mRNA undergoes alterna-
tive circularization to produce multiple circRNA variants.
RT-PCR analyses, using divergent oligonucleotide pairs for
each SMN internal exon (with the exception of exon 2a
for which we did not obtain reproducible results, data not
shown), uncovered expression of numerous potential SMN
circRNAs in both SMA fibroblasts and HEK293T cells
(Figure 3C). Direct sequencing of these transcripts con-
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Figure 1. Invasion of inverted repeat Alu elements characterizes the human SMN locus. (A) Graphic representation of non-LTR (SINE and LINE) and
LTR elements in the human SMN1 and murine Smn gene (https://genome.ucsc.edu). (B, C) Box plots made with R (v3.2.3) represent the density of Alu
elements in all human genes, only genes with Alu (B) in coding (C), non coding (NC) genes and in genes with undetermined function (Und) (C). The
colored circle highlights the position of SMN genes. C versus NC P-value = 1.09e−53; C versus Und P-value = 3.49e−25; NC versus Und P-value =
1.50e−71. (D) Schematic representation of the human SMN locus with indicated the number of introns and position of Alus. SMN exons are indicated
with black boxes. Alu elements are indicated with red arrows, the direction of the arrow indicates the orientation of the element. Red and green lines show
the inter- and intra-intronic pairing between IRAlus, respectively. Blue lines show the pairing between intergenic and intronic regions.
firmed that they originate from back-splicing, it revealed
that they utilize both canonical and cryptic splice sites (ex-
ons 2b, 3 and 8) for circularization and defined their al-
ternative exon number and assortment (Figure 3C, D). We
found that even the SMN last exon (exon 8), which does not
contain a canonical 5′ splice site, is included in circRNAs.
Indeed, sequencing analysis revealed that Exon 3′dwr-6-7-
8 and Exon 8-6-7 circRNAs exploit a cryptic 5′ splice site
located at nucleotide 143 of exon 8. This splice site either
back-splices with exon 6 or it splices linearly with a cryptic
exon located 169 bp downstream of exon 8 (3′dwr), which
back-splices with exon 6 (Figure 3C, D). Based on circRNA
abundance, SMN exon 4 and exon 6 are themost used exons
in the back-splicing events that we identified (Figure 3C,D).
This observation suggests a functional role of the Alu re-
peats contained in intron 4 (AluY, +295/+576 and AluSx1,
+938/+1199; Figure 1D) and intron 5 (AluSq, +393/+671;
Figure 1D) as key elements involved in SMN circRNAs
biogenesis. In particular, our bioinformatics analysis of se-
quence complementarity suggests that intron 4 preferen-
tially pairs with intron 1, intron 2a and intron 6, possibly
mediating the formation of back-splice junctions 4-2a, 4-2b
and 6-5, respectively. Likewise, intron 5 likely participates
to the biogenesis of other two circRNAs (junctions 3′dwr-6
and 8-6) (Supplementary Figure S2C, Table S4). Notably,
every SMN internal exon participates to circRNA biogen-
esis and even Alus contained in very short introns seem
to be involved in the promotion of back-splicing events.
These findings indicate that the SMN pre-mRNA under-
goes widespread alternative circularization in human cells.
Interfering with SMN circRNAs biogenesis affects the ex-
pression of SMN protein
To investigate whether strengthening IRAlu pairing favours
SMN circRNAbiogenesis, we knocked downDHX9, which
was previously reported to cause a global increase in cir-
cRNA biogenesis (29). As expected, depletion of DHX9
in HEK293T cells significantly increased the expression of
SMN circRNAs (Figure 4A, B), as well as the control cir-
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Figure 2. Inverted repeat Alus negatively impact on SMN transcript processing. (A) qPCR analyses of the ratio between distal and proximal pre-mRNA
region of human (hSMN2) and mouse (mSmn) SMN gene (mean ± SD, n = 5; ***P ≤ 0.001, unpaired t-test). The analysis was performed in hepatocytes
isolated from liver of wild type mice (P1) harboring the human SMN2 transgene. (B) Box plots representing the density of the Alu elements in Alu-
containing coding (C), non coding (NC) genes and in genes with undetermined function (Und). Boxplots were performed using R (v3.2.3). The red circle
highlights the position occupied by SMN genes and other colored circles indicate the position occupied by high- (MARVELD2 and GOT2) and low-Alu
(CTDSP2 and POLI) genes. (C) Bar graphs showing results of qPCR analyses of the ratio between distal and proximal pre-mRNA region of high- and
low-Alu genes, as indicated (mean ± SD, n = 3). (D) Bar graphs showing results of qPCR analyses of the ratio between distal and proximal pre-mRNA
region of SMN and low-Alu genes, as indicated. The analysis was performed by comparing human HEK293T and murine hepatocyte cell lines (mean ±
SD, n = 3). (E) Western blot analysis of DHX9 in total extracts of DHX9-depleted cells (HEK293T). Actin was evaluated as loading control. (F) qPCR
analyses of the ratio between distal and proximal pre-mRNA region of human SMN gene in DHX9-depleted cells (HEK293T) (mean ± SD, n = 5; *P ≤
0.05; unpaired t-test). (G) A workflow for detection of BrU-labeled nascent RNAs. HEK293T cells silenced or not for DHX9 were treated with DRB for 6
h to block transcription and BrU-labeled newly synthesized total RNAs were collected 1 h after DRB removal. BrU-labeled nascent RNAs were purified
by anti-BrdU antibody and subjected to RT-qPCR analysis. (H) qPCR analysis of nascent SMN transcripts labeled with BrU in DHX9-depleted cells
(HEK293T). Novel transcripts were immunoprecipitated by using specific anti-BrdU antibody and analyzed with the indicated primers (left side). Cells
not treated with BrU were used as control of the immunoprecipitation. The graph represents the ratio between mRNA versus pre-mRNA of specific SMN
regions. The value of siCtrl cells was set as reference (mean ± SD, n = 3; ∗p ≤ 0.05, **P ≤ 0.01; unpaired t-test). (I) Representative images (left panel)
and densitometry (right panel) of the western blot analyses of DHX9, SMN and GEMIN 2 expression in DHX9-depleted cells (HEK293T). Actin was
evaluated as loading control (mean ± SD, n = 3; *P ≤ 0.05, **P ≤ 0.01, ns not significant; unpaired t-test).
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Figure 3. The SMN pre-mRNA undergoes widespread alternative circularization. (A) Schematic representation of the human SMN pre-mRNA. Boxes
represent exons, black lines represent introns. Exons in light blue (exon 2a and exon 6) represent the SMN circular RNA-forming exons and the white box
indicates the last annotated exon of SMN. A circRNA is produced by back-splicing event joining the downstream 5′ donor site of exon 6 to upstream 3′
acceptor site of exon 2a. Black arrows indicate divergent oligonucleotide pairs utilized to amplify the SMN circRNA. Red arrows indicate theAlu elements
contained in SMN intron 1 and intron 6 possibly involved in the circularization of SMN pre-mRNA. (B) Representative images of RT-PCR analyses for
SMN circRNA (Exon 6-2a-2b) expression in human type-I SMA fibroblasts (GM03813) and HEK293T cells following RNAse R treatment. LinSMN1/2-
FL and linSMN1/2-5 stand for the linear counterpart of SMN transcripts containing or not the variable exon 5, respectively. The lower panel is the
electropherogram showing the SMN circRNA-specific splice junction (indicated by a black bar) detected in the RT-PCR product. (C) Conventional PCR
assays performed in human type-I SMA fibroblasts (GM03813) and in human HEK293T cells by using divergent (DIV) oligonucleotide pairs for each
coding exon of SMN gene after RNAse R treatment. Mouse brain was used as negative control of PCR. Colored arrows indicate all sequenced SMN
circRNAs; each color corresponds to a specific SMN circRNA whose exon composition is highlighted in the legend on the right. c5′ or c3′ SS stands for
cryptic 5′ or 3′ splice site utilized for circularization. 3′dwr stands for 3′ downstream region indicating a cryptic exon of 98 bp involved in circularization
and located downstream from the last annotated exon of SMN. (D) Electropherograms showing the circRNA-specific splice junction detected in the RT-
PCR products. Splice junctions are indicated by a black bar. The nucleotide sequences of PCR products that apparently follow a linear exon number were
obtained by using a reverse primer and correspond to a back-splice junction. On the right side, graphic representation of SMN circRNA containing that
specific splice junction is illustrated. Arrows indicate the cryptic 3′ or 5′ SS involved in the back-splicing event and the nucleotide position that they occupy.
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Figure 4. Interfering with SMN circRNAs biogenesis affects the expression of SMN protein. (A) Western blot analysis of DHX9 in DHX9-depleted
cells (HEK293T). Actin was evaluated as loading control. (B) qPCR analysis for indicated back-splice junctions in DHX9-depleted cells (HEK293T).
CircBRIP1, known to be regulated by DHX9 (29), was used as positive control. RPL34 was used to normalize RNA content in parallel RT-PCR reactions
omitting RNAse R treatment (mean ± SD, n = 3; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; unpaired t-test). (C) Schematic representation of splicing and
back-splicing events that generate the two exon 8-containing SMN circRNA, as indicated in the figure. Exons are represented as boxes and introns as lines.
In blue and in white are indicated the coding and the non-coding exons, respectively. Shown below is the nucleotide sequence of SMN exon 8 and in red is
indicated the cryptic 5′ splice site (c 5′SS) involved in the back-splicing event with the 3′ splice site of exon 6. The sequence of ASO-E8 is highlighted in the
rectangle. pA stands for poly A site and 3′dwr stands for 3′ downstream region indicating a cryptic exon of 98 bp involved in circularization and located
downstream from exon 8 of SMN. (D) Representative images of RT-PCR analysis for the indicated SMN2 circRNAs in ASO treated cells (GM03813).
ASO-C is a control morpholino. (E) Representative images (left panel) and densitometry (right panel) of western blot for SMN and GEMIN 2 in ASO
treated cells (GM03813). Actin was evaluated as loading control (mean ± SD, n = 5; *P ≤ 0.05, ns not significant; unpaired t-test).
cBIRP1 (29). Since DHX9 depletion also caused a reduc-
tion in SMNprotein expression (Figure 2I), we asked if lim-
itingSMN circRNAbiogenesis could lead to significant res-
cue of SMN protein expression. To evaluate this possibility
by a simple, straightforward strategy, we focused on SMN
circRNAs generated by back-splicing of a 5′ splice site not
used for linear SMN splicing (Supplementary Figure S3A).
The biogenesis of two exon 8-containing circRNAs employs
a cryptic 5′ splice site embedded in exon 8 (Exon 3′dwr-6-
7-8 and Exon 8-6-7; Figure 3C, D). Thus, we developed an
ASO (ASO-E8) thatmasks this 5′ splice site (Figure 4C) and
tested its efficacy in the modulation of exon 8-containing
circRNAs. ASO-E8 administration in human SMA fibrob-
lasts selectively reduced the target SMN circRNAs without
impairing the production of other SMN circRNAs (Figure
4D). Furthermore, although this ASO targeted only a mi-
nority of circRNAs and did not significantly affect expres-
sion of SMN2 pre-mRNA (Supplementary Figure S3B), it
caused amild but significant rescue (∼20%) of SMNprotein
expression (Figure 4E). These results indicate that biogen-
esis of SMN circRNAs is targetable by ASO strategies and
suggest that it competes with the protein-coding potential
of the locus.
Sam68 binds Alu-rich introns in SMN and promotes pre-
mRNA circularization
Short and highly conserved inverted repeat sequences are
sufficient to stabilize RNA secondary structures and to
promote circRNA biogenesis (30). In depth analysis of
SMN IRAlus identified 228 highly conserved (100% iden-
tity) short sequences (25–53 bp) that occur at least once
in inverted orientation in SMN (Supplementary Table S1)
and are significantly conserved in other primates (92–100%
identity) but not in mouse Smn (Supplementary Table S2).
Three core sequences are particularly abundant and re-
peated multiple times in inverted orientation along the
gene and downstream of the last SMN exon (Figure 5A;
Supplementary Table S3). Moreover, ∼50% of these ultra-
conserved motifs map toAluY, Sx1 and Sq (Supplementary
Figure S4) and these Alu elements flank exons that more
frequently participate to biogenesis of the circRNAs de-
tected in our experiments (exon 4 and exon 6, see Figure
3C, D). Thus, the higher propensity of these Alu elements
to pair may be related to the high abundance of such ultra-
conserved motifs.
Since RBPs that recognize intronic regions, such as
QKI, were shown to promote circRNA biogenesis (22,23),
we searched for RBP-specific motifs within these se-
quences. We identified strong binding sites for four RBPs:
Sam68, TIA-1 and hnRNP F/H (Figure 5B). Two of these
(Sam68 and TIA-1) also regulate splicing of the disease-
associated SMN2 exon 7 (31–33). Knockdown experiments
in HEK293T cells (Figure 5C) indicated that depletion of
Sam68 caused a significant reduction in the expression of
several SMN circRNAs, whereas TIA-1 and hnRNP F/H
silencing exerted no significant effect (Figure 5D).
Sam68 is a homolog ofQKI and binds toRNAas a dimer
(34), thus displaying key features required to stabilize in-
tronic pairing and to promote circRNA biogenesis (22,23).
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Figure 5. Sam68 binds Alu-rich introns in SMN and promotes pre-mRNA circularization. (A) Graphic representation of the human SMN locus. Exons
are indicated with black boxes and introns with lines. Colored arrows represent the identified conserved motifs within Alu elements. Their orientation is
indicated by the direction of the arrow. The nucleotide sequences of the three motifs are indicated. (B) Predicted binding sites for Sam68, hnRNP F/H
and TIA1 were identified (SpliceAid: database of RNA-Splicing Proteins binding). (C) Western blot analysis for indicated proteins in Sam68-, hnRNP
F/H- and TIA1-depleted cells (HEK293T). Actin was evaluated as loading control. (D) qPCR analysis for indicated back-splice junctions in Sam68-,
hnRNP F/H- and TIA1-depleted cells (HEK293T). RPL34 was used to normalize for RNA content in parallel RT-PCR reactions omitting RNAse R
treatment (mean ± SD, n = 3/5; ∗p ≤ 0.05, ∗∗p ≤ 0.01, ***P ≤ 0.001; unpaired t-test). (E, F) CLIP assay of Sam68 (E, F), hnRNP F/H (E) and TIA-1
(E) binding to the SMN pre-mRNA. HEK293T cells were UV-crosslinked and immunoprecipitated with control IgGs or antibodies, as indicated. The
bar graph shows qPCR signals amplified in CLIP assays expressed as enrichment versus IgG. The value of IgGs was set as 1. The upper panel shows a
schematic representation of SMN gene structure and the Alu-overlapping regions amplified by qPCR are indicated with black arrows. The white arrow in
panel E indicates the amplified region across exon 2b–intron 2b junction that does not contain Alus (mean ± SD, n = 6; *P ≤ 0.05, **P ≤ 0.01, ***P ≤
0.001; unpaired t-test). (G) qPCR analysis for the indicated SMN2 back-splice junctions in cerebellum of adult Sam68 wild type (Sam68+/+) and knockout
mice (Sam68−/−) harboring the human transgene SMN2++. Murine L34 (mL34) was used to normalize for RNA content (mean ± SD, n = 3/6; *P ≤
0.05, **P ≤ 0.01; unpaired t-test).
To test whether Sam68 actually binds SMN pre-mRNA in
proximity of Alus, we performed UV crosslink immunopre-
cipitation (CLIP) experiments. Strikingly, strong binding of
Sam68 was observed in close proximity of Alus contain-
ing motifs 1 and 3 sequences, whereas hnRNP F/H bound
weakly and TIA-1 binding was barely detectable (Figure
5E). Sam68 CLIP signals map to Alus located in proxim-
ity of splice sites that are well-positioned to promote back-
splicing of exon 4with exon 2a or exon 2b and of exon 8with
exon 6. Notably, Sam68 binding near these Alus was pro-
moted by depletion of DHX9 (Supplementary S5A), thus
correlating with increased SMN circRNA production (Fig-
ure 4B). Furthermore, we observed that Sam68 CLIP sig-
nals gradually decreased when qPCR primers were posi-
tioned at further distance from Alus (Figure 5F). These ob-
servations indicate that Sam68 preferentially binds in prox-
imity of Alu-rich regions in SMN introns.
We previously reported that knockout of Sam68 in SMA
mice rescued SMN2 exon 7 splicing, SMN protein expres-
sion and ameliorated the SMA phenotype (31). To evalu-
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ate the production of SMN circRNAs in a physiological
context, we analysed their expression in a mouse model of
SMA (SMN27;SMN2++;Smn+/−) that is either wild type
or knockout for the Sam68 gene (31). qPCR analyses using
primers specific for the circular splice junctions 4-2a, 4-2b,
6-2a and 3′dwr-6 indicated that circRNAs are produced by
the human SMN2 gene in various brain regions, with max-
imal expression in the cerebellum (Supplementary Figure
S5B-E). Each SMN circRNA represented a small percent-
age (0.035–1.3%) of linear SMN2 transcript in vivo (Supple-
mentary Figure S5F), with no significant differences in their
expression between wild type and SMA mice (Supplemen-
tary Figure S5G). Importantly, Sam68 is also expressed at
higher levels in cerebellum with respect to other brain re-
gions (35), suggesting that it may be implicated in SMN
circRNA biogenesis in this brain region. In line with this
hypothesis, we observed that knockout of the Sam68 gene
in the same mouse background caused a significant reduc-
tion of all three SMN circRNAs tested (Figure 5G). These
findings support a new role for Sam68 in SMN circRNA
biogenesis.
Sam68 cooperates with IRAlu-rich introns in SMN circRNA
biogenesis
Sam68 recognizes single-strand A/U-rich bipartite motifs
as a dimer in target transcripts (36,37). Since such high-
affinity binding sites were also very abundant in the regions
flanking the Alus, we hypothesized that Sam68 binding to
these Alu-proximal regions and its homodimerization may
contribute to bring in close proximity IRAlus that are lo-
cated in distant introns, thus favoring circRNA biogenesis.
To test this hypothesis, we constructed a minigene encom-
passing the SMN coding region from exon 5 to the region
downstream of exon 8, comprising the cryptic exon (3′dwr)
that back-splices with exon 6. An internal portion of intron
6 was deleted to reduce the size of the minigene, while a
six-nucleotide tag was inserted in exon 6 to allow discrim-
ination of the recombinant RNA products from endoge-
nous transcripts (Figure 6A). Transfection of the minigene
inHEK293T cells resulted in the production of the expected
3′dwr-6-7-8 circRNA (Figure 6B), indicating that it is suit-
able to study SMN circRNAbiogenesis. Importantly, trans-
fection in hepatocytes that are either wild type or knock-
out for Sam68 indicated that this minigene-derived SMN
circRNA is sensitive to Sam68 expression, as its produc-
tion was reduced in knockout cells and rescued by transfec-
tion of recombinant Flag-Sam68 (Figure 6C). Next, we per-
formed deletion mutagenesis of intron 5 to eliminate either
theAlu or a downstream flanking region enriched in Sam68
binding sites (Figure 6D). Both deletions caused a signifi-
cant reduction of 3′dwr-6-7-8 circRNA expression (Figure
6E). However, concomitant deletion of both theAlu and the
Sam68 binding region elicited an additive effect and almost
completely abolished circularization (Figure 6E). Neither
deletion impaired linear splicing of exon 6, indicating that
thesemutations did not disrupt the 3′ splice site at the intron
5–exon 6 junction. These results suggest that Sam68 coop-
erates with IRAlu pairing to promote circularization of the
SMN pre-mRNA.
DISCUSSION
The human SMN locus is almost twice the size of the
mouse Smn locus and much of this difference is caused
by an extensive invasion of Alu elements that has occurred
upon evolution. Due to such pervasive insertion of Alu ele-
ments, human SMN ranks among the genes with the high-
est Alu density, many of which are present in inverted ori-
entation (IRAlus). Alus can impact on several layers of
host gene regulation, ranging from transcription to trans-
lation (27). Here, we show that IRAlus negatively affect
RNAPII transcriptional dynamics and pre-mRNAprocess-
ing within SMN, thus likely reducing the transcriptional
potential of the locus. Furthermore, IRAlus promote al-
ternative back-splicing events, yielding multiple circRNAs.
Knockdown of DHX9, a helicase which destabilizes IRAlu
paring and represses circRNA biogenesis (29), further re-
duced the processing of Alu-rich introns in the SMN locus
and increased the concentration of SMN circRNAs, sug-
gesting that a delay in intron splicing may offer a window
of opportunity for pairing of distal introns through IRAlus
and promotion of back-splicing events. These findings sup-
port a role of IRAlus as key regulatory determinants of
SMN expression in primates, which may have implica-
tions in neurodegenerative diseases linked to reduced SMN
function (4).
For many human genes just one or few circRNAs have
been described, suggesting the involvement of a limited
number of exons that are generally flanked by long in-
trons (17,18). By contrast, our results indicate that the
SMN pre-mRNA undergoes alternative back-splicing reg-
ulation to generate many circRNAs characterized by vari-
able exon number and assortment, with virtually every exon
participating to circRNA biogenesis. Sequencing analysis
indicated that, in addition to the involvement of canoni-
cal splice sites, SMN circRNAs also originate from back-
splicing of cryptic splice sites. For instance, the biogenesis
of two SMN circRNAs (Exon 3′dwr-6-7-8 and Exon 8-6-
7) employed a cryptic 5′ splice site embedded in exon 8,
which is the last annotated exon in linear SMN mRNA.
Noteworthy, Exon 3′dwr-6-7-8 and Exon 8-6-7 SMN cir-
cRNAs include the variable exon 7 also in SMA fibroblasts
(GM03813), whereas this exon is skipped in 85–90% of lin-
ear SMN2 transcripts (4). This observation suggests that
splicing of SMN2 exon 7 is differentially regulated in lin-
ear and circular transcripts. It will be interesting to inves-
tigate whether its preferential inclusion in circRNAs may
contribute to limiting full-length expression ofSMN2 linear
mRNA.
While two of the identified SMN circRNAs (i.e.
hsa circ 0002251 and hsa circ 0072853) were previously
annotated in the online repository circBase (http://www.
circbase.org), our work highlights the widespread nature
of SMN pre-mRNA circularization and suggests the func-
tional impact of this process in the regulation of the locus.
While our manuscript was in preparation, similar findings
were reported by another study, which also describes exten-
sive circRNAbiogenesis from the SMN locus (38). Notably,
all the circRNAs that we have identified were also found in
this other study, indicating that these molecules are not ran-
dom by-products, but rather their detection and isolation is
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Figure 6. Sam68 cooperates with IRAlu-rich introns in SMN circRNA biogenesis. (A) Schematic representation of circSMN minigene. Boxes represent
exons, black lines represent introns and the white boxes indicate the non-coding exons of SMN. The nucleotide sequence indicates the six nucleotide TAG
inserted into the SMN exon 6. (B) Representative image of RT-PCR analysis for minigene-derived SMN back-splice junction (3′dwr-6 J) in HEK293T
transfected with empty vector (/) or with circSMN minigene (MG). linSMN-FL and linSMN-7 stand for linear SMN transcripts full length or exon
7 skipped, respectively. (C) qPCR analysis for the minigene-derived SMN back-splice junction (3′dwr-6 J) in Sam68 wild type (Sam68+/+), knockout
hepatocytes (Sam68−/−) and knockout hepatocytes reconstituted with Flag-SAM68 (Sam68−/− + Flag-Sam68). The linear transcript encoded by the
minigene (PCI-Ex6) was used to normalize for RNA content (mean ± SD, n = 3; **P ≤ 0.01, ***P ≤ 0.001 (Sam68+/+ versus Sam68−/− or Sam68−/− +
Flag-Sam68); §§§P≤ 0.001 (Sam68−/− versus Sam68−/− + Flag-Sam68); one-way ANOVA). (D) Schematic representation of mutant circSMNminigenes
used. Mut#1, #2 and #3 stand for deletion mutant #1, #2 and #3, respectively. WT stands for wild type minigene. (E) qPCR analysis for the minigene-
derived SMN back-splice junction (3′dwr-6 J) in hepatocytes wild type. The 3′dwr-6 junction was normalized with PCI-Ex6 amplicon as in (C). Murine
L34 was used to normalize for RNA content (mean ± SD, n = 3; ***P ≤ 0.001 (WT versus Mut#1 or #2 or #3); §p ≤ 0.05 (Mut#1 versus Mut#3); ##P
≤ 0.01 (Mut#2 versus Mut#3); one-way ANOVA).
highly reproducible from multiple cell lines using various
experimental approaches. For this reason, SMN circRNAs
could represent good candidates as biomarkers in SMA pa-
tients. Since a role for SMN in transcriptional termination
control has been described (39), it is conceivable that SMN
circRNAs extending beyond the canonical last exon 8 are
preferentially expressed in the body fluids of SMA patients,
in which SMN expression is very low. Thus, they might rep-
resent a valid parameter to predict the onset and the pro-
gression of disease and to stratify SMApatients that exhibit
different responses to therapy in spite of similar or identical
genetic diagnosis.
Our work shows that even Alus contained in very short
introns are active in SMN circRNA biogenesis. Indeed, we
observed that exon 4 and 6 are most frequently involved
in SMN back-splicing events, suggesting that IRAlus con-
tained in the flanking introns (AluY andAluSx1 in intron 4,
AluSq in intron 5) are particularly prone to pairing, which
may be related to the high representation of the short ultra-
conserved sequences in these elements. Most SMN circR-
NAs identified herein belong to two groups: a proximal
group containing exons 2a-4 (SMN circRNAs Exon 4-2a-
2b-3, Exon 4-2b-3 and Exon 4-2b) that utilizes intron 4
pairing with upstream introns and a distal group contain-
ing exons 5-8 that utilizes pairing of intron 4 with intron
6 (SMN circRNA Exon 6-5) or of intron 5 with the inter-
genic region (3′dwr) located downstream of exon 8 (SMN
circRNAs Exon 3′dwr-6-7-8 and Exon 8-6-7). Thus, these
intronic SMN regions appear to contribute alternative sec-
ondary structures that are likely to impact on the regulation
of pre-mRNA processing.
Mounting evidence supports the hypothesis that inser-
tion of Alu elements in SMN has added additional lay-
ers of gene regulation upon evolution. In addition to the
Alu-dependent transcriptional (RNAPII processivity) and
post-transcriptional (intron splicing) regulation described
in our study, exonization of an Alu element in intron 6
(exon 6B) was shown to augment the transcript variants
produced by human SMN (40,41). Interestingly, exon 6B-
containing SMN transcripts encode for a protein (SMN6B)
that is less stable than the full-length SMN. Thus, elucidat-
ing the molecular mechanism by which the presence of Alu
elements modifies the protein-coding potential of the SMN
genes may provide additional targets to enhance SMN2 ex-
pression in SMA cells and animal models. In this regard,
our study shows that repression of a small percentage of
circRNAs exerts a mild but significant impact on SMN
expression. We designed an ASO (ASO-E8) to target the
cryptic 5′ splice site in SMN exon 8, thus interfering with
the expression of two exon 8-containing circRNAs (Exon
3′dwr-6-7-8 and Exon 8-6-7). Since ASO-E8 administration
specifically repressed the expression of these SMN circR-
NAs and slightly increased SMN protein expression, pre-
mRNA circularization and/or other Alu-mediated mech-
anisms may directly affect SMN expression. Indeed, it is
also possible that the numerous Alu elements contained in
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the SMN promoter and 3′ untranslated regions contribute
to regulation of transcription, stability and translation of
SMN transcripts.
Bioinformatics analyses highlighted three short se-
quences (23–25 bp) within SMN Alus that are ultra-
conserved in primates and occur multiple times in inverted
orientation within the locus. Their orientation and proxim-
ity to splice sites suggested to us that they may promote
alternative back-splicing events. Indeed, short inverted se-
quences are sufficient to promote intron pairing and pre-
mRNA circularization (30). Since some RBPs can pro-
mote circRNA biogenesis by binding to intronic regions
and facilitating their pairing through homo- or hetero-
dimerization (22,23), we searched for RBP motifs enriched
within these ultra-conserved sequences. The analysis iden-
tified strong binding sites for Sam68, TIA-1 and hnRNP
F/H. Of these RBPs, only Sam68 appeared to play a role
in SMN circRNA biogenesis and its effect seems to be di-
rect. Sam68 strongly binds the SMN pre-mRNA in prox-
imity of intronic Alu elements and its knockdown signif-
icantly reduces the expression of SMN circRNAs. Since
Sam68 binding to RNA requires its dimerization (34), this
RBP is well suited to promote looping between introns and
to contribute to circRNAs biogenesis, by bringing close to
each other back-splice sites that would otherwise be dis-
tant. Thus, Sam68 dimerization may cooperate with IRAlu
pairing to bring intronic regions in close proximity. In sup-
port of this hypothesis, our mutagenesis studies indicate
that deletion of the Alu in intron 5, or of the Sam68 bind-
ing sites downstream of it, caused a significant reduction
of the 3′dwr-6-7-8 circRNA. Furthermore, combined dele-
tion of these intronic elements almost completely abolished
circRNA biogenesis, thus suggesting a cooperative action
of the Alu and Sam68 to promote SMN pre-mRNA cir-
cularization. As Alus show a high degree of conservation
in the human genome, it is conceivable that Sam68 might
have a more general role in circRNA biogenesis in human
cells. It is also interesting that almost half of the Sam68-
bound short ultra-conserved motifs map to younger Alu el-
ements (42). Thus, Sam68, as well as other RBPs regulating
the biogenesis of such circRNAs, may have only recently ac-
quired new regulatory functions. Since circRNAs accumu-
late in brain with ageing (43) and their dysregulation pos-
sibly contributes to neurodegenerative diseases (44), modu-
lating their expression in the brain may have both physio-
logical and pathological consequences.
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